Dapagliflozin propanediol monohydrate
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dapagliflozin propanediol monohydrate, covering 2026-03-13 to 2026-03-13. Get the full timeline:
Most recent: EMA Authorised: Qtern (saxagliptin;dapagliflozin propanediol monohydrate) — Astra Zeneca AB